ImmunityBio (IBRX) Other financing activities (2014 - 2026)
ImmunityBio (IBRX) posted quarterly Other financing activities of $53.5 million for Q1 2026, up 242.84% quarter-over-quarter from $15.6 million in Q3 2024.
Powered by 
Analysis
ImmunityBio (IBRX) Other financing activities (2014 - 2026) Analysis & Trends
ImmunityBio (IBRX) has reported Other financing activities for 10 consecutive years, with $53.5 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Other financing activities changed N/A year-over-year to $53.5 million; the TTM figure through Mar 2026 stood at $53.5 million (down 21.7% YoY), while the FY2024 annual figure was $73.3 million, changed N/A from the prior year.
- Other financing activities climbed to $53.5 million in Q1 2026 per IBRX's latest filing, from $15.6 million in the prior quarter.
- Across five years, Other financing activities topped out at $53.5 million in Q1 2026 and bottomed at -$126000.0 in Q2 2023.
- Historically, Other financing activities has averaged $17.0 million across 4 years, with a median of $7.1 million in 2023.
- Annual changes were most pronounced in 2022 — Other financing activities sank 93.4% — and 2024, when it soared 41976.19%.
- ImmunityBio's Other financing activities stood at -$74000.0 in 2022, then slumped by 70.27% to -$126000.0 in 2023, then jumped by 12494.44% to $15.6 million in 2024, then soared by 242.84% to $53.5 million in 2026.
- Business Quant data shows IBRX's Other financing activities at $53.5 million in Q1 2026, $15.6 million in Q3 2024, and $52.8 million in Q2 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | ImmunityBio | 8.51 Bn | 8.15 Bn | 50.94 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 53.54 Mn |
| Jun 30, 2025 | -220,000.00 |
| Mar 31, 2025 | 220,000.00 |
| Sep 30, 2024 | 15.62 Mn |
| Jun 30, 2024 | 52.76 Mn |
| Mar 31, 2024 | 14.12 Mn |
| Jun 30, 2023 | -126,000.00 |
| Mar 31, 2023 | 126,000.00 |
| Dec 31, 2022 | -74,000.00 |
| Mar 31, 2022 | 74,000.00 |
| Dec 31, 2021 | 351,000.00 |
| Sep 30, 2021 | 1.40 Mn |
| Jun 30, 2021 | 3.31 Mn |
| Mar 31, 2021 | 1.12 Mn |
| Dec 31, 2020 | 259,000.00 |
| Sep 30, 2020 | 400,000.00 |
| Jun 30, 2020 | 600,000.00 |
| Sep 30, 2019 | -49,000.00 |
| Mar 31, 2019 | 39.22 Mn |
| Dec 31, 2018 | 43,000.00 |